The Patent Finder

Fit Biotech Oy

Also on record
Records under this name other than patents Fit Biotech Oy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Fit Biotech Oy

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,474,800Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
Lapsed on the fee record
Ended Oct 25, 2024 · USPTO record
Lapsed on the fee recordEnded Oct 25, 2024USPTO record
US 9,725,486Methods of treating HIV diseases using novel expression vectors
Lapsed on the fee record
Ended Aug 8, 2021 · USPTO record
Lapsed on the fee recordEnded Aug 8, 2021USPTO record
US 7,521,182Selection system containing non-antibiotic resistance selection marker
Lapsed on the fee record
Ended Apr 21, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 21, 2021USPTO record
US 7,510,718Expression vectors and uses thereof
Lapsed on the fee record
Ended Mar 31, 2021 · USPTO record
Lapsed on the fee recordEnded Mar 31, 2021USPTO record
US 7,498,314Expression vectors and uses thereof
Lapsed on the fee record
Ended Mar 3, 2021 · USPTO record
Lapsed on the fee recordEnded Mar 3, 2021USPTO record
US 6,479,279Episomal vectors and uses thereof
Term ended
Term ended Dec 29, 2015 · USPTO record
Term endedTerm ended Dec 29, 2015USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited